Chuckle. Just Peter....... don't forget, my baby is "margin-pain", mired down in dead money land.
No, my trades have done well, but my "picks" (SIBI, BTRN, etc.) have even underperformed von Emster. But, he fails to point out that his record (1) stinks, and (2) indicates that he's not following his own advice. See the AGPH thread..... the SOB shorted it.
That's number one. Number two, he sells and does substantial damage to the sector, not when the relative valuations and science dictate that one *should* sell, but when the seasons change or after a given meeting, or when he's got a bad zit, etc. Then, to top it off, he goes public trying to put spin on the sector as a whole or to cover his own inept trading.
Biotech would be better off without the likes of von Emster. I wonder if Franklin's management knows that he's underperforming to the point of being an embarrassment.
Biotech fund managers should either be strong proponents of the science, or the funds should be named Franklin Superstition Fund, Franklin Incompetent Fund, Franklin Biobunk Fund, etc. |
